BARBANENTE, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 473
EU - Europa 118
AS - Asia 59
OC - Oceania 2
Totale 652
Nazione #
US - Stati Uniti d'America 471
SE - Svezia 48
SG - Singapore 36
IT - Italia 32
CN - Cina 22
BE - Belgio 10
GB - Regno Unito 10
DE - Germania 6
FR - Francia 4
FI - Finlandia 3
AU - Australia 2
CA - Canada 2
CZ - Repubblica Ceca 2
LT - Lituania 1
NL - Olanda 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 652
Città #
Chandler 100
Fairfield 47
New York 42
Nyköping 40
Singapore 32
Wilmington 26
Houston 23
Woodbridge 23
Ann Arbor 22
Seattle 22
Ashburn 21
Cambridge 16
Lawrence 11
Brussels 10
Roxbury 7
Bari 5
London 5
Molfetta 5
Munich 5
Beijing 4
Boardman 4
Des Moines 4
Paris 4
Princeton 4
Helsinki 3
Inglewood 3
Los Angeles 3
San Diego 3
Arzano 2
Jinan 2
Melbourne 2
Nanjing 2
Triggiano 2
Wuhan 2
Wuxi 2
Amsterdam 1
Bisceglie 1
Bratislava 1
Brno 1
Casapesenna 1
Dearborn 1
Heze 1
Markham 1
Mikulov 1
Milan 1
Noicattaro 1
Norwalk 1
Ottawa 1
Phoenix 1
San Jose 1
Santa Clara 1
Shanghai 1
Taizhou 1
Tashkent 1
Washington 1
Youngstown 1
Zhongshan 1
Totale 530
Nome #
A Pt(IV) prodrug of kiteplatin with the bone-targeting pyrophosphate ligand 128
One-Pot Synthesis of New Organometallic Compounds with Platinum-Carbon Bond 67
null 60
Platinum(IV) complexes of trans-1,2-diamino-4-cyclohexene: Prodrugs affording an oxaliplatin analogue that overcomes cancer resistance 58
Selenium-doped hydroxyapatite nanoparticles for potential application in bone tumor therapy 44
Platinum-loaded, selenium-doped hydroxyapatite nanoparticles selectively reduce proliferation of prostate and breast cancer cells co-cultured in the presence of stem cells 42
A minimal structural variation can overcome tumour resistance of oxaliplatin: the case of 4,5-dehydrogenation of the cyclohexane ring 37
Preclinical evaluation of platinum-loaded hydroxyapatite nanoparticles in an embryonic zebrafish xenograft model 36
Effect of chirality on the anticancer activity of Pt(II) and Pt(IV) complexes containing 1R,2R and 1S,2S enantiomers of the trans-1,2-diamino-4-cyclohexene ligand (DACHEX), an analogue of diaminocyclohexane used in oxaliplatin 34
Pt(IV) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activity 33
New Oxaliplatin-Pyrophosphato Analogs with Improved In Vitro Cytotoxicity 31
Interaction of Copper Trafficking Proteins with the Platinum Anticancer Drug Kiteplatin 24
Cisplatin and zoledronic acid: two drugs combined in a Pt(II) complex with potential antitumor activity towards bone tumors and metastases 18
Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral Administration 15
Cytotoxic pathways activated by multifunctional thiosemicarbazones targeting sigma-2 receptors in breast and lung carcinoma cells 13
Molecular Dynamics and Structural Studies of Zinc Chloroquine Complexes 12
Multinuclear Metal-Binding Ability of the N-Terminal Region of Human Copper Transporter Ctr1: Dependence Upon pH and Metal Oxidation State 11
null 10
Tryptophan regulates Drosophila zinc stores 9
Flying toward a plastic-free world: Can Drosophila serve as a model organism to develop new strategies of plastic waste management? 8
Pt(II) complex containing the 1R,2R enantiomer of trans-1,2-diamino-4-cyclohexene ligand effectively and selectively inhibits the viability of aggressive pancreatic adenocarcinoma cells and alters their lipid metabolism 6
Pt(ii) and Pt(iv) complexes with a major component of royal jelly as innovative antitumor drug candidates 5
The mechanism of antiproliferative activity of the oxaliplatin pyrophosphate derivative involves its binding to nuclear DNA in cancer cells 4
Interactions with DNA Models of the Oxaliplatin Analog (cis-1,3-DACH)PtCl2  2
Totale 707
Categoria #
all - tutte 4.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.997


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202070 0 0 0 0 8 9 8 9 12 17 0 7
2020/2021105 0 6 1 12 8 0 15 15 6 23 6 13
2021/202294 3 2 1 1 3 16 1 4 15 11 15 22
2022/2023198 28 36 16 10 27 27 5 12 22 3 9 3
2023/2024122 8 17 2 23 7 48 3 0 1 5 0 8
2024/202590 20 4 17 18 31 0 0 0 0 0 0 0
Totale 707